Related Experiment Video
Updated: Jun 13, 2026
11:27
Analysis of SCAP N-glycosylation and Trafficking in Human Cells
Published on: November 8, 2016
SREBPs in Metabolic Reprogramming and Disease: Mechanisms and Therapeutic Potential
Xinhong Zou1, Yingyu Li1, Mu Yang1
1Clinical Medicine Department, Jiamusi University, Jiamusi, Heilongjiang Province, China.
Summary
Sterol regulatory element-binding proteins (SREBPs) are crucial for lipid metabolism and homeostasis. This review details their roles in metabolic diseases and explores therapeutic strategies targeting SREBP signaling pathways.
Area of Science:
- Molecular Biology
- Cellular Metabolism
- Biochemistry
Background:
- Sterol regulatory element-binding proteins (SREBPs) are key transcription factors regulating lipid metabolism.
- SREBPs are essential for maintaining cellular metabolic homeostasis.
- Dysregulation of SREBP signaling is implicated in various diseases.
Purpose of the Study:
- To systematically review SREBP structure, activation, and regulatory mechanisms.
- To outline SREBP-mediated lipid metabolic programs and their role in disease.
- To discuss therapeutic strategies targeting SREBP signaling.
Main Methods:
- Literature review and systematic summary of existing research on SREBPs.
- Analysis of SREBP activation pathways, including the INSIG-SCAP-SREBP complex.
- Cross-disease overview of SREBP-driven metabolic reprogramming.
Main Results:
- SREBPs control de novo lipogenesis, triglyceride accumulation, cholesterol metabolism, and membrane remodeling.
- SREBP dysregulation contributes to inflammation, immune imbalance, and malignant progression.
- Emerging small-molecule modulators show therapeutic potential for SREBP-related diseases.
Conclusions:
- SREBPs are central regulators of lipid metabolism and link metabolic changes to disease progression.
- Targeting SREBP signaling offers promising therapeutic avenues for metabolic diseases.
- Further research is needed to overcome challenges in SREBP-targeted therapies.
Related Concept Videos
01:27Transducer Mechanism: Enzyme-Linked Receptors
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
01:29Somatic to iPS Cell Reprogramming
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012 for this...
01:19Regulation of Metabolism
Cellular needs and conditions vary from cell to cell and change within individual cells over time. For example, the required enzymes and energetic demands of stomach cells are different from those of fat storage cells, skin cells, blood cells, and nerve cells. Furthermore, a digestive cell works much harder to process and break down nutrients during the time that closely follows a meal compared with many hours after a meal. As these cellular demands and conditions vary, so do the amounts and...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:31Regulation of the Unfolded Protein Response
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...